Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin effects on mitochondrial function in PCOS
NCT02198417Unknown
- Sponsor
- Massachusetts General Hospital
- Start
- Jul 2014
- Primary completion
- Sep 2020
- Modality
- Small Molecules
01
Overview
Open-label, single-arm trial of metformin in polycystic ovary syndrome (PCOS), sponsored by Massachusetts General Hospital. Primary endpoint: Muscle Metabolism/Mitochondrial Function at 3 months. Status: unknown.
02
Drugs
metformin
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on NCT02198417.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02198417.